ACE inhibitors with thiazides

Introduction

Angiotensin-converting enzyme (ACE) inhibitors with thiazides are fixed-dose combination medications that pair two antihypertensive classes:

1. ACE inhibitors – block the conversion of angiotensin I to angiotensin II, leading to vasodilation, reduced aldosterone secretion, decreased sodium/water retention, and improved vascular compliance.

2. Thiazide diuretics – inhibit sodium-chloride reabsorption in the distal convoluted tubule, leading to natriuresis, mild diuresis, and reduced plasma volume, which lowers blood pressure.

The rationale for combining them is based on synergistic effects:

• Thiazides cause RAAS activation, which can be counterbalanced by ACE inhibitors.

• ACE inhibitors can mitigate thiazide-induced hypokalemia.

• Combination allows for better blood pressure control at lower doses, improving tolerability.

These combinations are widely prescribed for essential hypertension when monotherapy is insufficient.

---

Mechanism of Action

• ACE inhibitors (e.g., lisinopril, enalapril, benazepril):

  • Block ACE enzyme → ↓ angiotensin II → vasodilation.

  • ↓ aldosterone → less sodium and water reabsorption.

  • ↑ bradykinin (vasodilatory peptide), enhancing vasodilation but contributing to cough.

• Thiazides (e.g., hydrochlorothiazide, chlorthalidone, indapamide):

  • Inhibit NaCl cotransporter in distal tubule → ↑ sodium, chloride, and water excretion.

  • ↓ plasma volume and cardiac output initially; long-term BP reduction is due to ↓ peripheral vascular resistance.

Synergy: The diuretic offsets ACE inhibitor–induced fluid retention, while the ACE inhibitor counters thiazide-induced RAAS activation and potassium loss.

---

Common ACE Inhibitor + Thiazide Combinations

1. Lisinopril + Hydrochlorothiazide

• Doses: 10/12.5 mg, 20/12.5 mg, 20/25 mg once daily.

• Widely used fixed-dose combination for hypertension.

2. Enalapril + Hydrochlorothiazide

• Doses: 10/25 mg or 20/12.5 mg once daily.

• Effective in patients uncontrolled on enalapril alone.

3. Benazepril + Hydrochlorothiazide

• Doses: 5/6.25 mg, 10/12.5 mg, 20/12.5 mg, 20/25 mg.

4. Captopril + Hydrochlorothiazide

• Doses: 25/15 mg, 25/25 mg, 50/25 mg.

• Older combination, shorter-acting.

5. Quinapril + Hydrochlorothiazide

• Doses: 10/12.5 mg, 20/12.5 mg, 20/25 mg.

6. Ramipril + Hydrochlorothiazide

• Doses: 2.5/12.5 mg, 5/25 mg.

(Other less common combinations include moexipril/HCTZ, perindopril/indapamide, etc.)

---

Therapeutic Uses

• Hypertension (primary indication):

  • For patients uncontrolled on ACE inhibitor monotherapy.

  • Provides additive BP reduction with a single pill → improves adherence.

• High-risk cardiovascular patients:

  • May be used in patients with diabetes, CKD, or heart failure with hypertension, though ACE inhibitor alone often preferred initially.

• Resistant hypertension:

  • Step-up therapy when lifestyle and single-drug regimens are inadequate.

---

Adverse Effects

From ACE inhibitors

• Dry cough (due to bradykinin accumulation).

• Angioedema (rare, potentially life-threatening).

• Hyperkalemia (especially with renal impairment).

• Hypotension (notably after first dose, especially in volume-depleted patients).

• Renal impairment (in bilateral renal artery stenosis or severe CKD).

From Thiazides

• Electrolyte abnormalities: Hypokalemia, hyponatremia, hypomagnesemia, hypercalcemia.

• Metabolic effects: Hyperuricemia (gout), hyperglycemia, increased cholesterol and triglycerides.

• Dehydration, orthostatic hypotension in elderly.

Combination-specific

• ACE inhibitor partly mitigates thiazide-induced hypokalemia.

• Still risk of renal dysfunction and electrolyte imbalance → monitoring essential.

---

Contraindications

• Pregnancy (ACE inhibitors are teratogenic).

• History of ACE inhibitor–induced angioedema.

• Bilateral renal artery stenosis.

• Severe renal impairment (creatinine clearance <30 mL/min for many combinations).

• Hyperkalemia.

---

Drug Interactions

• NSAIDs: Reduce antihypertensive effect, increase risk of renal dysfunction.

• Potassium-sparing diuretics/potassium supplements: Increase risk of hyperkalemia.

• Lithium: ACE inhibitors reduce lithium clearance → risk of toxicity.

• Antidiabetic agents: Thiazides may blunt glucose control.

• Alcohol, antihypertensives: Additive hypotensive effects.

---

Clinical Considerations

• Initiation: Usually reserved for patients whose BP is not controlled with ACE inhibitor monotherapy.

• Monitoring: Renal function (serum creatinine, eGFR), electrolytes (potassium, sodium), blood pressure response.

• Elderly: Start with lower doses; increased sensitivity to orthostatic hypotension.

• Adherence benefit: Single pill combinations reduce pill burden and improve compliance.

• Efficacy: Combination therapy reduces systolic and diastolic BP more effectively than either alone, with fewer dose-related side effects.